Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis

Hepato-Gastroenterology

Volumn 53, Issue 69, 2006, Pages 473-478

  Kunisaki, Chikara ^a   Shimada, Hiroshi ^a   Akiyama, Hirotoshi ^a   Nomura, Masato ^a   Matsuda, Goro ^a   Otsuka, Yuichi ^a   Ono, Hidetaka ^a   Takahashi, Masazumi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Continuous hyperthermic peritoneal perfusion; Gastric cancer; Peritoneal carcinomatosis

Indexed keywords

CISPLATIN; ETOPOSIDE; MITOMYCIN C;

ADULT; ARTICLE; CANCER SURVIVAL; CARCINOMATOSIS; CHEMOTHERAPY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CYTOLOGY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERITONEUM CANCER; PRIORITY JOURNAL; RESPIRATORY FAILURE; STOMACH CANCER; UNIVARIATE ANALYSIS;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33745443535     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Louvet C, Andre T, Tigaud JM, Gamelin E, Douvillard JY, Brunet R, Francois E, Jacob JH, Levoir D, Taamma A, Rougier P, Cvitkovic E, Gramont A: Phase II study of oxaliplatin, fluorouracil, and folic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol 2002; 20:4543-4548.
2. Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H, Yamamichi N, Miyata Y, Ikeda N, Yamamoto S, Fukuda H, Yoshida S: Randomized Phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japanese Clinical Oncology Group Study (JCOG9205). J Clin Oncol 2003; 21:54-59.
3. Shimada S, Yagi Y, Kuramoto M, Aoki N, Ogawa M: Second-line chemotherapy with combined irinotecan and low-dose cisplatin for patients with metastatic gastric carcinoma resistant to 5-fuorouracil. Oncol Rep 2003; 10:687-691.
4. Fujimoto S, Takahashi M, Kobayashi K, Nagano K, Kure M, Mutoh T, Ohkubo H: Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis. Cancer 1992; 70:2754-2760.
5. Sugarbaker PH: Management of peritoneal surface malignancy: the surgeon's role. Langenbeck's Arch Surg 1999; 384:576-587.
6. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I: Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991; 15:530-536.
7. Japanese Research Society for Gastric Cancer: Japanese Classification of Gastric Carcinoma 1st English Edition. Tokyo, Kanehara & Co., Ltd., 1995.
8. Urano M, Kuroda M, Nishimura Y: For the clinical application of thermochemotherapy given at mild temperature. Int J Hyperthermia 1999; 15:79-107.
9. Horsman MR, Overgaard J: Can mild hyperthermia improve tumour oxygenation? Int J Hyperthermia 1997; 13:141-147.
10. Song CW, Shakil A, Osborn JL, Iwata K: Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia 1996; 12:367-373.
11. Song CW, Kang MS, Rhee JG, Levitt SH: The effect of hyperthermia on vascular function, pH, and cell survival. Radiology 1980; 137:795-803.
12. Fujimoto S, Shrestha RD, Lokubun M, Ohta M, Takahashi M, Kobayashi K, et al: Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988; 208:36-41.
13. Hirose K, Katayama K, Iida A, Yamaguchi A, Nakagawara G, Umeda S, Kusaka Y: Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: Evaluation by multivariate regression analysis. Oncology 1999; 57:106-114.
14. Beaujard AC, Glehen O, Caillot JL, Francois Y, Bienvenu J, Panteix G, Garbit F, Grandclement E, Vignal J, Gilly FN: Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000; 88:2512-2519.
15. Jacquet P, Stephens AD, Averbach AM, Chang D, Ettinghausen SE, Dalton RR, Steves MA, Sugarbaker PH: Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996; 77:2622-2629.
16. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH: Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 1998; 228:347-354.
17. Lawrance RJ, Loizidou M, Cooper AJ, Alexander P, Taylor I: Importance of the omentum in the development of intra-abdominal metastases. Br J Surg 1991; 78:117-119.
18. Wheatley DN, Ambrose EJ, Easty GC: Infiltration of intra-abdominal organs by ascites tumors. Nature 1963; 199:188-189.
19. Yonemura Y, Fujimura T, Fushida S, Fujita H, Bando E, Nishimura G, Miwa K, Endou Y, Tanaka M, Sasaki T: A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination. Hepatogastroenterology 1999; 46:601-609.
20. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, Francois Y, Vignal J, Gilly FN: Peritoneal carcinomatosis form non-gynecologic malignancies. Cancer 2000; 88:358-363.
21. Loggie BW, Fleming RA, McQuellon RP, Russel GB, Geisinger KR: Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 2000; 66:561-568.
22. Glehen O, Mithieux F, Osinsky D, Beaujard AC, Freyer G, Guertsch Ph, Francois Y, Peyrat P, Panteix G, Vignal J: Surgery Combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J Clin Oncol 2003; 21:799-806.
23. Shen P, Levine EA, Hall J, Case D, Russel G, Fleming R, McQuellon R, Geisinger KR, Loggie BW: Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003; 138:26-33.
24. Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinsky D, Freyer G, Francois Y, Vignal J, Gilly FN: Cytoreductive surgery and intraperitoneal chemohyperthermic for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004; 139:20-26.